Literature DB >> 18154864

Management of patients who have undergone head and neck cancer therapy.

Dena J Fischer1, Joel B Epstein.   

Abstract

Patients who undergo treatment for head and neck cancers often suffer from acute or late reactions to therapy. Severity of these oral complications may be based on the location and extent of tumor, as well as the type and extent of treatment. Some complications are transient, whereas others require a lifetime of management secondary to damage that results in permanent dysfunction. Patients who have a history of head and neck cancers are also at an increased risk for recurrences or second malignancies, and therefore require close follow-up. Dental professionals should provide preventive and supportive care, including education and symptom management, for patients experiencing oral complications related to cancer therapy, and should closely monitor patients' level of distress, ability to cope, and treatment response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18154864     DOI: 10.1016/j.cden.2007.09.004

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN: 0011-8532


  10 in total

Review 1.  A systematic review of oral fungal infections in patients receiving cancer therapy.

Authors:  Rajesh V Lalla; Marie C Latortue; Catherine H Hong; Anura Ariyawardana; Sandra D'Amato-Palumbo; Dena J Fischer; Andrew Martof; Ourania Nicolatou-Galitis; Lauren L Patton; Linda S Elting; Fred K L Spijkervet; Michael T Brennan
Journal:  Support Care Cancer       Date:  2010-05-08       Impact factor: 3.603

2.  Periodontal care in patients undergoing radiotherapy for head and neck cancer.

Authors:  Audrey Cristina Bueno; Raquel Conceição Ferreira; Flávia Isabela Barbosa; Bruno Correia Jham; Cláudia Silami Magalhães; Allyson Nogueira Moreira
Journal:  Support Care Cancer       Date:  2012-10-02       Impact factor: 3.603

3.  Chronic oral mucositis after radiotherapy to the head and neck: a new insight.

Authors:  Sharon Elad; Yehuda Zadik
Journal:  Support Care Cancer       Date:  2016-07-30       Impact factor: 3.603

4.  Effect of therapeutic doses of radiotherapy on the organic and inorganic contents of the deciduous enamel: an in vitro study.

Authors:  Elza Maria de Sá Ferreira; Luis Eduardo Silva Soares; Héliton Spíndola Antunes; Sofia Takeda Uemura; Patrícia da Silva Barbosa; Hélio Augusto Salmon; Giselle Rodrigues de Sant'Anna
Journal:  Clin Oral Investig       Date:  2015-12-22       Impact factor: 3.573

5.  Long-term oral effects in patients treated with radiochemotherapy for head and neck cancer.

Authors:  Aline Lima da Silva Deboni; Adelmo José Giordani; Nilza Nelly Fontana Lopes; Rodrigo Souza Dias; Roberto Araujo Segreto; Siri Beier Jensen; Helena Regina Comodo Segreto
Journal:  Support Care Cancer       Date:  2012-03-13       Impact factor: 3.603

6.  Onset of mandible and tibia osteoradionecrosis: a comparative pilot study in the rat.

Authors:  Monika Damek-Poprawa; Stefan Both; Alexander C Wright; Amit Maity; Sunday O Akintoye
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-12-17

Review 7.  Review of the complications associated with treatment of oropharyngeal cancer: a guide for the dental practitioner.

Authors:  Lena Turner; Muralidhar Mupparapu; Sunday O Akintoye
Journal:  Quintessence Int       Date:  2013-03       Impact factor: 1.677

8.  Expertise regarding dental management of oral cancer patients receiving radiation therapy among Western Australian dentists.

Authors:  Am Frydrych; Lm Slack-Smith; Jh Park; Ac Smith
Journal:  Open Dent J       Date:  2012-12-14

9.  Dynasplint Trismus System exercises for trismus secondary to head and neck cancer: a prospective explorative study.

Authors:  Jolanda I Kamstra; Harry Reintsema; Jan L N Roodenburg; Pieter U Dijkstra
Journal:  Support Care Cancer       Date:  2016-03-08       Impact factor: 3.603

Review 10.  Loss of Olfactory Function-Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders.

Authors:  Heike Rebholz; Ralf J Braun; Dennis Ladage; Wolfgang Knoll; Christoph Kleber; Achim W Hassel
Journal:  Front Neurol       Date:  2020-10-26       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.